Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services
Candice E. Crocker, Alix Carter, Jason G. Emsley, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Cannabis-Related Disorders and Toxic Effects
David A. Gorelick
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2267-2275
Closed Access | Times Cited: 16
Post-reform cannabis use and major depressive episode: A naturalistic investigation
Sumona Hoque Mumu, Tayo Nafisat Folorunso, Jacqueline Pokuaa Badu, et al.
Journal of Contemporary Studies in Epidemiology and Public Health (2025) Vol. 6, Iss. 1, pp. ep25001-ep25001
Open Access
Synaptic changes induced by cannabinoid drugs and cannabis use disorder
Shana M. Augustin, David M. Lovinger
Neurobiology of Disease (2022) Vol. 167, pp. 105670-105670
Closed Access | Times Cited: 26
Cannabis Legalization and the Decline of Cannabis Use Disorder (CUD) Treatment Utilization in the US
Jeremy Mennis, Gerald J. Stahler, Michael J. Mason
Current Addiction Reports (2023) Vol. 10, Iss. 1, pp. 38-51
Closed Access | Times Cited: 15
Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences
Justin Matheson, Bernard Le Foll
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 15
A Case of First-Episode Psychosis with Catatonic Features in an Adolescent Following THC Use
Lily Porsa
Psychiatry Research Case Reports (2025), pp. 100248-100248
Open Access
Self-reported mental health during the COVID-19 pandemic and its association with alcohol and cannabis use: a latent class analysis
Nibene Habib Somé, Samantha Wells, Daniel Felsky, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Cannabis-only use in the USA: prevalence, demographics, use patterns, and health indicators
Beatriz H. Carlini, Gillian L. Schauer
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 17
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
Christopher N. Andrews, Renata Rehak, Matthew Woo, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 11-12, pp. 1532-1542
Closed Access | Times Cited: 17
SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence
Monica Sabbineni, William H. Scott, Kiran Punia, et al.
Academic Emergency Medicine (2023) Vol. 31, Iss. 5, pp. 493-503
Closed Access | Times Cited: 8
A systematic review and meta-analysis of synthetic cathinone use and psychosis
Rishika R Daswani, Cassandra M Choles, David D. Kim, et al.
Psychopharmacology (2024) Vol. 241, Iss. 5, pp. 875-896
Closed Access | Times Cited: 2
Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada
Nibene Habib Somé, Mostafa Shokoohi, Kevin D. Shield, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
A cross-sectional study of the relationship between frequency of cannabis use and psychiatric symptoms among people seeking mental health and addiction services in Nova Scotia (2019–21)
Lu Yang, Philip G. Tibbo, Sherry H. Stewart, et al.
Journal of Psychiatric Research (2024) Vol. 173, pp. 104-110
Open Access | Times Cited: 1
Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study
Stephen D.S. McCarthy, Jennifer Xiao, Michael Pugliese, et al.
The Lancet Regional Health - Americas (2024) Vol. 36, pp. 100815-100815
Open Access | Times Cited: 1
“Like the Wild West”: Health care provider perspectives on impacts of recreational cannabis legalization on patients and providers at a tertiary psychiatric hospital in Ontario, Canada
Jessica L. Wiese, Tara Marie Watson, Nikki Bozinoff, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 167, pp. 209487-209487
Open Access | Times Cited: 1
Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies
Divya Vimal, Leonard Clinton D’Souza, Vipin Rai, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 2, pp. 178-202
Closed Access | Times Cited: 6
The Co-occurrence of Gastrointestinal Symptoms and Psychosis
Mark Ainsley Colijn
The Primary Care Companion For CNS Disorders (2022) Vol. 24, Iss. 3
Open Access | Times Cited: 6
Establishing diagnostic strategies for cannabis allergy
Alessandro Toscano, Jessy Elst, Marie‐Line M. van der Poorten, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 10, pp. 1015-1022
Closed Access | Times Cited: 6
Mental health adverse events with cannabis use diagnosed in the Emergency Department: what are we finding now and are our findings accurate?
Candice E. Crocker, Jason G. Emsley, Philip G. Tibbo
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 2
Evaluating the Supporting Evidence of Medical Cannabis Claims Made on Clinic Websites: Cross-Sectional Study
Braden O’Neill, Jacob Ferguson, Lauren Dalueg, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e45550-e45550
Open Access | Times Cited: 2
Cannabis Research and Therapeutics: An International Quasi-experiment in Cannabis Policy
Julie K. Johnson, Alexander Colby
Clinical Therapeutics (2023) Vol. 45, Iss. 6, pp. 488-493
Open Access | Times Cited: 2
Left hemisphere lateralization of the limbic system and frontoparietal network (FPN) correlates with positive and negative symptom improvement following cannabidiol (CBD) administration in psychosis and ultra-high risk (UHR) populations: A voxel-wise meta-analysis
Zachary P. Pierce, Andrew S. Bogatz, Emily Johnson, et al.
Journal of Psychiatric Research (2024) Vol. 175, pp. 160-169
Closed Access
The impact of recreational cannabis legalization on ED visit rates for acute cannabis intoxication
An Nguyen, Ray Lee, Lili Zhao, et al.
The American Journal of Emergency Medicine (2024) Vol. 84, pp. 124-129
Closed Access
Assessment of frontal lobe functions in a sample of male cannabis users currently in abstinence: correlations with duration of use and their functional outcomes
El-Shimaa Tag-Eldeen, Magda Fahmy, Khaled Anwar, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access
Cannabis and Driving in Australia and Canada: Exploring Stakeholders' Perspectives to Help Inform Education Initiatives
Estelle Pretorius
(2024)
Open Access
Page 1 - Next Page

Scroll to top